narvo vexar Activist investor Ancora Holdings is pressing H.B. Fuller ( FUL ) to drop its proposed takeover of UK-based Advanced Medical Solutions Group Plc. Ancora, which has more than a 2% stake in H.B. Fuller ( FUL ), wants the adhesive maker to abandon the AMS deal and instead start a full strategic review, including evaluating a potential sale, according to a statement on Tuesday. "The silver...
narvo vexar Activist investor Ancora Holdings is pressing H.B. Fuller ( FUL ) to drop its proposed takeover of UK-based Advanced Medical Solutions Group Plc. Ancora, which has more than a 2% stake in H.B. Fuller ( FUL ), wants the adhesive maker to abandon the AMS deal and instead start a full strategic review, including evaluating a potential sale, according to a statement on Tuesday. "The silver lining is the Board still has time to slam the brakes on an acquisition of AMS before further damaging H.B. Fuller’s credibility with shareholders and impairing the Company’s value in the market," Ancora Chairman and Chief Executive Officer Fred DiSanto and Ancora Alternatives President James Chadwick said in a letter dated May 23. The letter comes after Bloomberg reported on Friday that H.B. Fuller ( FUL ) bid more than £600 million ($806 million) for AMS, a British maker of tissue-healing medical products. "In closing, although we are prepared to hold leadership accountable for any value-destructive and ill-timed capital allocation blunders via a proxy fight next year, the goal from the start of our monthslong engagement with H.B. Fuller has been to work together in a constructive manner to enhance value for shareholders," DiSanto and Chadwick wrote. "You are welcome to draw us into a fight, but it is hard to remember the last time that worked out well for a corporate leadership team." H.B. Fuller ( FUL ) didn't immediately respond to Seeking Alpha's email request for comment. Shares of H.B. Fuller rose 1.3% on Tuesday. More on H.B. Fuller H.B. Fuller Company (FUL) Q1 2026 Earnings Call Transcript H.B. Fuller Company 2026 Q1 - Results - Earnings Call Presentation I'm Less Positive On H.B. Fuller After This Quarter (Downgrade) H.B. Fuller dividend preview: set for another dividend increase H.B. Fuller outlines $4.55–$4.90 EPS guidance and mid-single digit revenue growth amid supply chain volatility
If you foresee a bunch of Nintendo purchases in your future, Newegg’s deal on Nintendo gift cards might just help save your wallet. The retailer is offering a deal that lets gamers get $200 worth of credit towards games, consoles, and accessories for just $170. Best of all, the gift cards can stack in your account, letting you accrue enough to buy a Nintendo Switch 2 at a sweet discount. Nintendo ...
If you foresee a bunch of Nintendo purchases in your future, Newegg’s deal on Nintendo gift cards might just help save your wallet. The retailer is offering a deal that lets gamers get $200 worth of credit towards games, consoles, and accessories for just $170. Best of all, the gift cards can stack in your account, letting you accrue enough to buy a Nintendo Switch 2 at a sweet discount. Nintendo eShop gift cards Where to Buy: $200 $170 at Newegg ($200) $100 $89.99 at Costco ($100) You don’t have to buy gift cards to reap some savings on a Switch 2, though. Nintendo is currently offering a $499.99 “Choose Your Game” console bundle that includes a discounted game ( Donkey Kong Bananza , Pokémon Pokopia , or Mario Kart World ). Either way you go, it’s wise to buy a console ahead of the fall because Nintendo is raising the Switch 2’s price by $50 — up to $499.99 — in September . window.HYPE_DESK_CONFIG = { productImageUrl: "https://s3.us-east-1.amazonaws.com/assets.sbnation.com/csk/uploads/hype-desk/product-images/macbook+neo.png", productImageAlt: "Apple MacBook Neo", productTitle: "Apple MacBook Neo", shortDescription: "An affordable, well-built laptop for a great price.", longDescription: "Apple's most affordable Mac ever starts at $599, and it does not feel like a compromise. The MacBook Neo has a durable aluminum enclosure that comes in four colors, and the battery life can handle everything you throw at it every day. Students and educators can save even more off an already surprising price.", purchaseUrl: "https://apple.sjv.io/c/482924/3875167/7613", purchaseLinkText: "Buy at Apple" }; Other deals you might dig Last week, we highlighted a deal on the Sonos Roam 2 , which is down to $134 (usually $179). Sonos improved on its own deal by offering the wireless, water-resistant speaker with Otterbox’s protective carrying case (originally $39.95) included for no extra charge. This case doesn’t take away from the Roam 2’s slick design — it just adds protection for its ...
Miyako Nakamura/iStock via Getty Images CytomX Therapeutics' ( CTMX ) Varseta-M (varsetatug masetecan) has demonstrated clear efficacy in colorectal cancer ( CRC ), albeit with some toxicity, but has potential in multiple other cancer indications. When I last wrote about CTMX in December 2025, I rated the name a buy, noting a Q1'26 readout from their CRC trial was high risk, although Varseta-M cou...
Miyako Nakamura/iStock via Getty Images CytomX Therapeutics' ( CTMX ) Varseta-M (varsetatug masetecan) has demonstrated clear efficacy in colorectal cancer ( CRC ), albeit with some toxicity, but has potential in multiple other cancer indications. When I last wrote about CTMX in December 2025, I rated the name a buy, noting a Q1'26 readout from their CRC trial was high risk, although Varseta-M could be worth billions alone in CRC. This article looks at the road ahead for the company following the Q1'26 data update, which the company used to raise further funds, potentially securing the ability to develop the drug into an agent with utility in multiple cancers. The phase 1 CRC trial update CTMX's trial of Varseta-M, an EpCAM-targeting antibody-drug conjugate, in late-line metastatic CRC patients provided an update in March 2026, along with Q4'25 earnings, with the company having dosed 93 patients at that time. The company now notes a 32% objective response rate ( ORR ) response rate seen with 10 mg/kg Varseta-M, which although down from a 43% reported at this dose in May 2025, is still an impressive display in a patient population that has already received prior lines of chemotherapy. The company notes an estimated progression free survival ( PFS ) of 7.1 months at the 10 mg/kg dose, although the 8.6 mg/kg dose is still in consideration for further work, and produced a 20% ORR an estimated 6.8 month PFS. CTMX presentation, May 2026. Side effects such as diarrhea do remain a concern, but at the time of the March update, CTMX noted it was now testing administration of budesonide (a steroid with activity in the gastrointestinal tract) to address some of those side effects. The company is also dosing the drug at adjusted ideal body weight (AIBW) dosages, in an attempt to make sure the dose is just right for the patient, which could also aid with balancing toxicity and efficacy. Initial data from the first 20 patients in that expansion, presented in March, noted a rate of...
美国独立炼油商PBF Energy Inc．今日宣布，公司计划公开发行5亿美元于2034年到期的优先无担保票据。此次发行将依照市场条件及其他因素进行，所募资金主要用于偿还2026年底到期的定期贷款及一般公司用途。 公告显示，此次发行的优先票据将由PBF Energy Inc．及其子公司PBF Finance Corporation作为共同发行人，部分现有及未来境内子公司提供担保。PBF Energ...
美国独立炼油商PBF Energy Inc．今日宣布，公司计划公开发行5亿美元于2034年到期的优先无担保票据。此次发行将依照市场条件及其他因素进行，所募资金主要用于偿还2026年底到期的定期贷款及一般公司用途。 公告显示，此次发行的优先票据将由PBF Energy Inc．及其子公司PBF Finance Corporation作为共同发行人，部分现有及未来境内子公司提供担保。PBF Energy计划于5月27日起面向合格机构投资者开展路演推介。 值得注意的是，就在此次融资计划宣布前一天，评级机构穆迪将PBF Energy的企业家族评级从“B3”下调至“Caa1”，展望维持“负面”，理由包括公司成本高企、炼油利润率环境充满挑战，以及年内将有多笔债务到期。此前，标普已于2025年11月将PBF的评级从“B-”下调至“CCC+”，同样持负面展望。在此背景下，此次融资被视为公司主动管理债务期限结构的积极举措。 从业务面看，PBF Energy近期迎来关键转折。公司此前公布的一季报显示，尽管录得调整后净亏损1.024亿美元，但标志着公司经营正从2025年2月的马丁内斯炼油厂火灾中逐步恢复。该炼油厂的催化裂化装置已于5月初开始生产成品油，标志着全面复产进程取得突破性进展。此外，公司成本优化计划成效显著，截至一季度末已实现2.3亿美元的年化运营成本节约，目标是到2026年底累计节约超过3.5亿美元。 此次5亿美元票据发行若顺利完成，将有助于PBF Energy优化债务结构，为马丁内斯炼油厂全面复产后的运营改善和现金流恢复提供财务支持。 责任编辑：张俊 SF065
Introduction Oracle ( ORCL ) has been dealing with many issues that I highlighted in my first coverage of the firm , and it has since depreciated by over 37%. With that in mind, I want to revisit my thesis and see if the situation now offers a better risk-to-reward ratio. Current Dynamics So, in my first coverage, I argued that the earnings release and the subsequent 36% surge in the stock price w...
Introduction Oracle ( ORCL ) has been dealing with many issues that I highlighted in my first coverage of the firm , and it has since depreciated by over 37%. With that in mind, I want to revisit my thesis and see if the situation now offers a better risk-to-reward ratio. Current Dynamics So, in my first coverage, I argued that the earnings release and the subsequent 36% surge in the stock price were a classic sell-the-news event, as the thesis rested on the massive RPO tied to only one customer that is not profitable, as in OpenAI, the deteriorating balance sheet, and the continuous increase in the valuation multiples. The stock peaked and then cratered by 61% to reach the low $130s range. The stock has since recovered, though my call became the consensus narrative based on an internal margin leak, a securities fraud class action, and the largest layoff in the firm’s history. I’ll say that the easy short is gone, but the structural concerns that drove my original take have not yet been resolved, especially considering that the convertibility of the RPO backlog into actual profit remains the biggest unanswered question in tech. According to internal documents reported by The Information , the company generated around $900MM from renting NVIDIA-powered AI servers with a gross profit of just $125MM, which would translate to a 14% gross margin vs. Oracle's overall corporate gross margin of around 70%. But Oracle’s response has been to guide AI gross margins to 30 to 40% over time , attributing the depressed near-term levels to delivery cost inefficiencies, bottlenecks, and current depreciation on hardware purchased ahead of customer ramp. But the bull case now requires investors to underwrite a margin trajectory that has not yet been demonstrated on hardware, which is still being commissioned to customers that are themselves burning $40B+ per year against a fraction of this in revenue. Though it is important to note that in the latest quarter, gross margin ran upwards ...
Introduction Oracle ( ORCL ) has been dealing with many issues that I highlighted in my first coverage of the firm , and it has since depreciated by over 37%. With that in mind, I want to revisit my thesis and see if the situation now offers a better risk-to-reward ratio. Current Dynamics So, in my first coverage, I argued that the earnings release and the subsequent 36% surge in the stock price w...
Introduction Oracle ( ORCL ) has been dealing with many issues that I highlighted in my first coverage of the firm , and it has since depreciated by over 37%. With that in mind, I want to revisit my thesis and see if the situation now offers a better risk-to-reward ratio. Current Dynamics So, in my first coverage, I argued that the earnings release and the subsequent 36% surge in the stock price were a classic sell-the-news event, as the thesis rested on the massive RPO tied to only one customer that is not profitable, as in OpenAI, the deteriorating balance sheet, and the continuous increase in the valuation multiples. The stock peaked and then cratered by 61% to reach the low $130s range. The stock has since recovered, though my call became the consensus narrative based on an internal margin leak, a securities fraud class action, and the largest layoff in the firm’s history. I’ll say that the easy short is gone, but the structural concerns that drove my original take have not yet been resolved, especially considering that the convertibility of the RPO backlog into actual profit remains the biggest unanswered question in tech. According to internal documents reported by The Information , the company generated around $900MM from renting NVIDIA-powered AI servers with a gross profit of just $125MM, which would translate to a 14% gross margin vs. Oracle's overall corporate gross margin of around 70%. But Oracle’s response has been to guide AI gross margins to 30 to 40% over time , attributing the depressed near-term levels to delivery cost inefficiencies, bottlenecks, and current depreciation on hardware purchased ahead of customer ramp. But the bull case now requires investors to underwrite a margin trajectory that has not yet been demonstrated on hardware, which is still being commissioned to customers that are themselves burning $40B+ per year against a fraction of this in revenue. Though it is important to note that in the latest quarter, gross margin ran upwards ...
As the first quarter earnings draws to a close, investors are focusing on updated quant ratings for firms for cues on their investments. Seeking Alpha’s quant ratings awards grades based on quantitative measures, like valuation, earnings growth, and recent stock performance. The highest possible score for any individual company is a 5. Below is a snapshot of small-cap consumer staple companies wit...
As the first quarter earnings draws to a close, investors are focusing on updated quant ratings for firms for cues on their investments. Seeking Alpha’s quant ratings awards grades based on quantitative measures, like valuation, earnings growth, and recent stock performance. The highest possible score for any individual company is a 5. Below is a snapshot of small-cap consumer staple companies with market capitalizations between $300M to $2B, highlighting the highest- and lowest-rated stocks by quant score following earnings season, and showcasing which companies improved their fundamentals versus those that underperformed. Top-quant rated stocks: Adecoagro ( AGRO ); Quant Rating: 4.75, Strong Buy John B. Sanfilippo & Son ( JBSS ); Quant Rating: 4.26, Buy Nature's Sunshine Products ( NATR ); Quant Rating: 4.17, Buy Herbalife ( HLF ); Quant Rating: 3.54, Buy The Honest Company ( HNST ); Quant Rating: 3.53, Buy Bottom quant rated stocks: Oddity Tech ( ODD ); Quant Rating: 1.03, Strong Sell Vital Farms ( VITL ); Quant Rating: 1.04, Strong Sell BellRing Brands ( BRBR ); Quant Rating: 1.05, Strong Sell Grocery Outlet Holding ( GO ); Quant Rating: 1.16, Strong Sell The Simply Good Foods Company ( SMPL ); Quant Rating: 1.17, Strong Sell More on Grocery Outlet, Herbalife, etc. Grocery Outlet Holding: Reiterate Sell Rating Given No Signs Of Strong Recovery Yet Adecoagro S.A. 2026 Q1 - Results - Earnings Call Presentation Oddity: Best To Wait For Definitive Clarity On CPA Headwinds Russell Microcap Index to add consumer discretionary names GoPro, Chegg, Dave & Buster’s GoPro, SES AI among consumer discretionary stocks to join the Russell 3000; Faraday Future, Travelzoo to exit
JHVEPhoto Mondelez International ( MDLZ ) announced on Tuesday that the Oreo brand is launching Limited Edition Oreo & BTS Cookies as part of a new global collaboration with K-pop supergroup BTS. The cookie collab will feature a brown sugar pancake–inspired flavor that gives a nod to the Korean street food hotteok. The Oreo product will be available in more than 80 markets for a limited time, star...
JHVEPhoto Mondelez International ( MDLZ ) announced on Tuesday that the Oreo brand is launching Limited Edition Oreo & BTS Cookies as part of a new global collaboration with K-pop supergroup BTS. The cookie collab will feature a brown sugar pancake–inspired flavor that gives a nod to the Korean street food hotteok. The Oreo product will be available in more than 80 markets for a limited time, starting with an online presale on June 1 and in stores on June 8. The cookies use purple golden wafers, echoing BTS’s signature color, and a multi-layer crème meant to capture the warm, caramelized brown sugar and pancake notes of hotteok. Each pack includes 13 unique cookie embossments designed by BTS to mark the band’s 13th anniversary, including member names, a BTS light stick, and three Oreo designs that combine to reveal a hidden message for fans. BTS is a seven-member South Korean boy band that debuted in 2013 and has since become one of the world’s most influential pop acts. Known for self-produced music, high-energy performances, and an in-depth relationship with their fanbase, the group has broken multiple global records and earned multiple Grammy nominations. The Seeking Alpha Quant Rating on MDL recently turned to Buy from Hold. The food stock also has a consensus Buy rating with Seeking Alpha analysts and Wall Street analysts. More on Mondelēz Mondelez: Profitability Normalization Creates A Major Opportunity (Rating Upgrade) Mondelez International, Inc. (MDLZ) Q1 2026 Earnings Call Transcript Mondelez International, Inc. 2026 Q1 - Results - Earnings Call Presentation U.S. struggles to define ‘ultraprocessed foods’ as Kennedy pushes crackdown Earnings scoreboard: 11 of 12 consumer staple names beat earnings estimates this week
Key Points The U.S. Department of Energy may allocate plutonium fuel to Oklo for its reactors. Oklo is partnering with Europe's newcleo to build plutonium-fueled nuclear reactors. 10 stocks we like better than Oklo › Oklo (NYSE: OKLO) stock soared 7.5% through 10:45 a.m. ET Tuesday morning after announcing the U.S. Department of Energy (DOE) has chosen it -- and four other nuclear power companies ...
Key Points The U.S. Department of Energy may allocate plutonium fuel to Oklo for its reactors. Oklo is partnering with Europe's newcleo to build plutonium-fueled nuclear reactors. 10 stocks we like better than Oklo › Oklo (NYSE: OKLO) stock soared 7.5% through 10:45 a.m. ET Tuesday morning after announcing the U.S. Department of Energy (DOE) has chosen it -- and four other nuclear power companies -- to negotiate for the right to participate in the Department's Surplus Plutonium Utilization Program. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » What is the Surplus Plutonium Utilization Program? Most nuclear reactors run on uranium fuel, which, as it decays, can transform into plutonium-239 (which fissions to produce heat), unless it absorbs another neutron to form plutonium-240 (which doesn't fission as easily) or another neutron to form plutonium-241 (which does)! The even-numbered isotopes that don't decay as easily accumulate over time, and can eventually end up as "spent" nuclear fuel, but even this fuel can be recycled into something a nuclear fast reactor can use as fuel. It's this fuel that Oklo would receive if it joins the program. What's next for Oklo If chosen, Oklo would partner with "newcleo," a European developer of advanced nuclear reactors, to help build its own reactors fueled with plutonium. This would "solve" several problems at once: First, by reducing "nuclear waste," second, by creating electricity to help fuel the artificial intelligence revolution, and third, by giving Oklo another source of fuel for its reactors. As Oklo CEO Jacob DeWitte confides, "fuel supply constraints are a key throttle to advanced reactor development," but "this program creates a pathway to use existing surplus material as bridge fuel for advanced reactors to bring more reactors online sooner." Admi...
The war in Iran commenced on Feb. 28, meaning March 2 was the first trading day on which investors could express their views on the conflict. Over the next three weeks, the S&P 500 dipped 4.4%. Caterpillar (CAT +2.62%), the second-largest member of the Dow Jones Industrial Average, was worse for wear, tumbling 6.7% over those three weeks. However, the industrial stock has since rebounded epically,...
The war in Iran commenced on Feb. 28, meaning March 2 was the first trading day on which investors could express their views on the conflict. Over the next three weeks, the S&P 500 dipped 4.4%. Caterpillar (CAT +2.62%), the second-largest member of the Dow Jones Industrial Average, was worse for wear, tumbling 6.7% over those three weeks. However, the industrial stock has since rebounded epically, gaining 9.9% for the month-long period ending May 22. That price action suggests Caterpillar is a buy, even if the war in Iran hasn't been officially resolved. But is it? Assuming the ceasefire holds, or the U.S. and Iran reach a deal to end the conflict, Caterpillar can retain the buy label and potentially position itself to make a run at the four-figure club. Maybe even as soon as next year. Maybe sooner. Let's examine what needs to go right for this stock to reach that rarefied air. Some moving pieces As it relates to the intersection of Caterpillar stock and the Iran war, there's at least one certainty: any renewed escalation of military action would likely weigh on the shares. The markets' initial reaction to the start of the war included punishment of cyclical stocks, of which Caterpillar is one, and materials stocks. That's relevant because the industrial machinery giant counts materials companies among its clients. Still, it's not a stretch to say Caterpillar's March weakness amid geopolitical volatility was more sentiment-driven than it was an indictment of the company's fundamentals. The company posted a 22% jump in first-quarter sales, which is impressive in its own right and even more so when considering that March is part of that quarter. The company also emerged from the quarter with a record backlog, indicating that customers continued to make purchases even as tensions flared in the Middle East. Caterpillar's top-line resilience in the face of geopolitical headlines is largely driven by its status as the industrial face of the artificial intelligence (AI) b...
Investing.com -- Bank of America has raised its price target on Apple to $380 per share from $330, arguing that the shift toward agentic artificial intelligence could unlock a significant new revenue opportunity for the iPhone maker and drive the next meaningful re-rating of the stock. In a note from analyst Wamsi Mohan, BofA said that in an agentic world, "value accrues to the platform that contr...
Investing.com -- Bank of America has raised its price target on Apple to $380 per share from $330, arguing that the shift toward agentic artificial intelligence could unlock a significant new revenue opportunity for the iPhone maker and drive the next meaningful re-rating of the stock. In a note from analyst Wamsi Mohan, BofA said that in an agentic world, "value accrues to the platform that controls user intent, personal context, app access, permissions, identity, authentication, payments, and trust," a description that maps closely to Apple's existing position. The firm explained that if AI assistants become the new front door to search, apps, commerce and payments, Apple should have "meaningful leverage over model providers, app developers, merchants, advertisers, and payment networks." BofA stated that Apple's agentic AI moat stems from its silicon and iOS stack, with Apple silicon determining how much inference can happen locally and iOS controlling whether AI can access user context, call apps and complete tasks in a trusted way. The firm outlined five priorities Apple needs to execute on, centered on evolving Siri into an orchestration layer capable of understanding intent, retrieving context and completing workflows. The financial opportunity substantial, in BofA's view. The firm estimated that an agentic Siri could represent a $15 billion to $30 billion incremental fiscal 2030 revenue opportunity in the base case and $40 billion to $65 billion in the bull case, potentially adding up to $2 in incremental earnings per share. BofA raised its price target to $380 based on 37 times its calendar year 2027 EPS estimate of $10.29, reiterating its Buy rating. Related articles Agentic AI can drive the next inflection in Apple’s valuation, BofA says These 2 stocks are best positioned to benefit from higher uranium prices: analyst This sector is 'poised for a big, beautiful year': Truist
8thCreator/iStock via Getty Images As I’ve covered in the past , I was bearish on Telefónica, S.A. ( TEF ) in the recent past, as the Spanish telecom company had a high-dividend yield that could be interesting for income-oriented investors, but I saw this as a dividend trap, and its valuation was not particularly cheap. Indeed, Telefonica revised its dividend policy some months ago and no longer o...
8thCreator/iStock via Getty Images As I’ve covered in the past , I was bearish on Telefónica, S.A. ( TEF ) in the recent past, as the Spanish telecom company had a high-dividend yield that could be interesting for income-oriented investors, but I saw this as a dividend trap, and its valuation was not particularly cheap. Indeed, Telefonica revised its dividend policy some months ago and no longer offers a high-dividend yield based on future expected dividends. Despite that, its shares have performed relatively well in recent months, recovering from a bottom under $4 per share, as investors reacted positively to its strategy update for the period 2026-30. Nevertheless, its shares are down by about 9% over the last year, showing that Telefonica has not created much value for investors despite its attractive dividend yield. Share price chart (Seeking Alpha) Dividend When I last covered Telefonica, its shares were offering a dividend yield of 7%, which was quite attractive to income-investors at first glance and was a higher yield than compared to most of its peers in the telecom sector, such as Vodafone ( VOD ) or Orange ( ORANY ). However, Telefonica’s dividend coverage based on both earnings and cash flow was not great, as the company was distributing some 85% of free cash flow to shareholders, not leaving much room for potential operational setbacks or to deleverage the balance sheet. While I was not expecting a dividend cut in the short term, I saw its dividend sustainability as questionable. This was largely justified by a weaker financial profile compared to peers, considering that Telefonica’s net debt-to-EBITDA ratio was among the highest across the European telecom sector. Moreover, its credit rating could eventually be cut to high yield if the company doesn't present a credit deleverage path ahead, something the company likely does not want to happen as it would lead to higher borrowing costs. Considering this backdrop of relatively high balance sheet leverage...
(RTTNews) - Shares of Spectral AI, Inc. (MDAI) are falling about 12 percent in Tuesday morning trading after the company announced that the U.S. Food and Drug Administration granted De Novo Classification for its DeepView System, which is used in burn care in various settings. The company's stock is currently trading at $2.34, down 12.72 percent, over the previous close of $2.68 on the Nasdaq. It ...
(RTTNews) - Shares of Spectral AI, Inc. (MDAI) are falling about 12 percent in Tuesday morning trading after the company announced that the U.S. Food and Drug Administration granted De Novo Classification for its DeepView System, which is used in burn care in various settings. The company's stock is currently trading at $2.34, down 12.72 percent, over the previous close of $2.68 on the Nasdaq. It has traded between $1.18 and $3.21 in the past one year. With this classification, Spectral AI is authorized to commence commercial distribution activities in the United States. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Ferrari (NYSE:RACE) shares fell 4.6% on Tuesday after the Italian automaker unveiled its first fully electric vehicle, the Luce, drawing criticism over its design and questions about the model's departure from the brand's identity. The four-door Luce, whose name is Italian for "light," was...
Ferrari (NYSE:RACE) shares fell 4.6% on Tuesday after the Italian automaker unveiled its first fully electric vehicle, the Luce, drawing criticism over its design and questions about the model's departure from the brand's identity. The four-door Luce, whose name is Italian for "light," was...